Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ricca DJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thor KB; Dignify Therapeutics, LLC, Durham, North Carolina kthor@dignifytherapeutics.com., Marson L; Dignify Therapeutics, LLC, Durham, North Carolina., Katofiasc MA; Dignify Therapeutics, LLC, Durham, North Carolina., Ricca DJ; Dignify Therapeutics, LLC, Durham, North Carolina., Burgard EC; Dignify Therapeutics, LLC, Durham, North Carolina.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Aug 19; Vol. 390 (3), pp. 302-317. Date of Electronic Publication: 2024 Aug 19.
Potency, efficacy, and selectivity of GR64349 at human recombinant neurokinin NK2 and NK1 receptors.
Autor:
Perdona E; Drug Design and Discovery, Aptuit an Evotec Company, via A. Fleming 4, 37135 Verona, Italy., Cavallini P; Drug Design and Discovery, Aptuit an Evotec Company, via A. Fleming 4, 37135 Verona, Italy., Sava A; Drug Design and Discovery, Aptuit an Evotec Company, via A. Fleming 4, 37135 Verona, Italy., Griffante C; Drug Design and Discovery, Aptuit an Evotec Company, via A. Fleming 4, 37135 Verona, Italy., Ricca DJ; Dignify Therapeutics LLC, Research Triangle Park, North Carolina, USA., Thor KB; Dignify Therapeutics LLC, Research Triangle Park, North Carolina, USA., Rupniak NMJ; Dignify Therapeutics LLC, Research Triangle Park, North Carolina, USA. Electronic address: nrupniak@dignifytherapeutics.com., Corsi M; Drug Design and Discovery, Aptuit an Evotec Company, via A. Fleming 4, 37135 Verona, Italy.
Publikováno v:
Neuroscience letters [Neurosci Lett] 2019 Oct 15; Vol. 711, pp. 134456. Date of Electronic Publication: 2019 Aug 22.
Autor:
Rupniak NMJ; Dignify Therapeutics LLC, 2 Davis Drive, P.O. Box 13169, Research Triangle Park, NC 27709, USA. Electronic address: nrupniak@dignifytherapeutics.com., Katofiasc MA; Dignify Therapeutics LLC, 2 Davis Drive, P.O. Box 13169, Research Triangle Park, NC 27709, USA., Marson L; Dignify Therapeutics LLC, 2 Davis Drive, P.O. Box 13169, Research Triangle Park, NC 27709, USA., Ricca DJ; Dignify Therapeutics LLC, 2 Davis Drive, P.O. Box 13169, Research Triangle Park, NC 27709, USA., Thor KB; Dignify Therapeutics LLC, 2 Davis Drive, P.O. Box 13169, Research Triangle Park, NC 27709, USA., Burgard EC; Dignify Therapeutics LLC, 2 Davis Drive, P.O. Box 13169, Research Triangle Park, NC 27709, USA.
Publikováno v:
Neuropeptides [Neuropeptides] 2019 Oct; Vol. 77, pp. 101956. Date of Electronic Publication: 2019 Jul 11.
Autor:
Rupniak NMJ; Dignify Therapeutics, Research Triangle Park, North Carolina, United States of America., Perdona E; Drug Design and Discovery, Aptuit an Evotec Company, Verona, Italy., Griffante C; Drug Design and Discovery, Aptuit an Evotec Company, Verona, Italy., Cavallini P; Drug Design and Discovery, Aptuit an Evotec Company, Verona, Italy., Sava A; Drug Design and Discovery, Aptuit an Evotec Company, Verona, Italy., Ricca DJ; Dignify Therapeutics, Research Triangle Park, North Carolina, United States of America., Thor KB; Dignify Therapeutics, Research Triangle Park, North Carolina, United States of America., Burgard EC; Dignify Therapeutics, Research Triangle Park, North Carolina, United States of America., Corsi M; Drug Design and Discovery, Aptuit an Evotec Company, Verona, Italy.
Publikováno v:
PloS one [PLoS One] 2018 Oct 25; Vol. 13 (10), pp. e0205894. Date of Electronic Publication: 2018 Oct 25 (Print Publication: 2018).
Autor:
Peterson JM; Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, USA., Kline W, Canan BD, Ricca DJ, Kaspar B, Delfín DA, DiRienzo K, Clemens PR, Robbins PD, Baldwin AS, Flood P, Kaumaya P, Freitas M, Kornegay JN, Mendell JR, Rafael-Fortney JA, Guttridge DC, Janssen PM
Publikováno v:
Molecular medicine (Cambridge, Mass.) [Mol Med] 2011 May-Jun; Vol. 17 (5-6), pp. 508-15. Date of Electronic Publication: 2011 Jan 20.
Autor:
Wang JKT; Cogent Neuroscience, Inc., Durham, NC 27704., Portbury S; Cogent Neuroscience, Inc., Durham, NC 27704., Thomas MB; Cogent Neuroscience, Inc., Durham, NC 27704., Barney S; Cogent Neuroscience, Inc., Durham, NC 27704., Ricca DJ; Cogent Neuroscience, Inc., Durham, NC 27704., Morris DL; Cogent Neuroscience, Inc., Durham, NC 27704., Warner DS; Multidisciplinary Neuroprotection Laboratories and Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710; and., Lo DC; Cogent Neuroscience, Inc., Durham, NC 27704; lo@neuro.duke.edu.; *Center for Drug Discovery and Department of Neurobiology, Duke University Medical Center, Durham, NC 27704.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2006 Jul 05; Vol. 103 (27), pp. 10461-10466. Date of Electronic Publication: 2006 Jun 22.
Autor:
Burgard EC; Dynogen Pharmaceuticals Inc, Durham, NC 27709, USA. eburgard@dynogen.com, Fraser MO, Karicheti V, Ricca DJ, Thor KB
Publikováno v:
Current opinion in investigational drugs (London, England : 2000) [Curr Opin Investig Drugs] 2005 Jan; Vol. 6 (1), pp. 81-9.